10-K Decoder · All companies

Neumora Therapeutics, Inc.

NMRA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$241M−$263M+8.5%
Net income−$237M−$244M+2.8%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 16, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$33.4M−$57.7M+42.1%
Net income−$34.4M−$56.8M+39.4%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Neumora's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Neumora profitable in FY2025?
No: net income was −$237M and operating income −$241M in FY2025.
What was Neumora's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 16, 2026.